2/19/2019WuXi STA and BioLingus Sign Exclusive Technology and Marketing Collabo...

2/16/2019PharmExec - New Roads to China

1/29/2019Pfizer China, PICC and MediTrust Co-launched China’s First Pay-for-Pe...

1/28/2019Advent International Makes Majority Investment in CRO Bioduro

1/25/2019Pfizer Supports Breast Cancer PBM Program in Shanghai

1/18/2019MabPlex's Manufactured mAb Receives IND Approval from the U.S. FDA

1/17/2019Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in Chi...

1/10/2019Pfizer Enters Strategic Cooperation with AliHealth for Drug Tracking a...

1/8/2019CANbridge Pharma and WuXi Biologics Expand Rare Disease Therapeutics P...

12/19/2018Pfizer and GSK Announce JV to Create a Global Consumer Healthcare Gian...

12/18/2018New Pfizer CEO's Top Priorities? Think China and Pipeline, Not Deals

12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...

12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...

12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite

11/29/2018Online Healthcare Platform Jianke.com to Form Alliance with Pfizer

11/29/2018WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...

11/29/2018Datwyler to Enter China to Meet Needs for Injectable Drug Components

11/27/2018WuXi Biologics Begins Construction of A Major Biologics Center in Shan...

11/12/2018Leading MNCs Tout Renewed China Business Growth in Q3

11/7/2018GE to Produce Single-Use Consumables in China thru Collaboration with ...

11/7/2018Pfizer Makes Bold Moves to Maximize China Business under New Leadershi...

10/25/2018WuXi AppTec Launches Drug Screening Library

10/25/2018Three Big Pharma Stocks Racing Along the Road to China

9/27/2018PharmaBlock Acquires Manufacturing Facility in China

9/20/2018Wuxi AppTech Submitted $1B+ IPO Application in Hong Kong

9/11/2018WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manu...

9/11/2018China CDMO Market 2018-2021: The R&D Cost of New Drugs Continues t...

8/9/2018Pfizer's Breast Cancer Drug Ibrance Receives Approval in China

7/25/2018WuXi STA's Jinshan API Plant Passes 4th U.S. FDA Inspection

7/20/2018WuXi STA and Antengene Sign Development and Manufacturing Agreement

Page:12/27 Total number of articles:794: [First][<<] [10] [11] [12] [13] [14] [>>] [End]